Survival is poor among patients with triple-class–exposed relapsed and refractory multiple myeloma. Idecabtagene vicleucel (ide-cel), a B-cell maturation antigen–directed chimeric antigen receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback